There is a problem with the stock price data. Our supplier is working to solve the issue.
Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+47.19%
Latest
+49.35%
3 months
Bryan GarnierPareto SecuritiesSEBSEB EquitiesCarnegieDanske BankDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Bryan Garnier340 SEKNov 13
+47.19%
Pareto Securities280 SEKOct 25
SEB415 SEKSep 29
SEB Equities410 SEKJun 21
Carnegie385 SEKApr 25
Danske Bank403 SEKOct -22
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion